AcouSort AB (OSTO:ACOU) ROCE % : -160.65% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is AcouSort AB ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. AcouSort AB's annualized ROCE % for the quarter that ended in Dec. 2023 was -160.65%.

AcouSort AB ROCE % Historical Data

The historical data trend for AcouSort AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AcouSort AB ROCE % Chart

AcouSort AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-89.58

-99.72

-56.75

-52.97

-79.33

AcouSort AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															-54.94	-69.73	-89.20	-154.61	-160.65

AcouSort AB ROCE % Calculation

AcouSort AB's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-17.089	/	( ( (41.491 - 22.541)	+	(34.513 - 10.378) )	/ 2 )
	=	-17.089	/	( (18.95	+	24.135)	/ 2 )
	=	-17.089	/	21.5425
	=	-79.33 %

AcouSort AB's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-26.224	/	( ( (16.055 - 7.543)	+	(34.513 - 10.378) )	/ 2 )
	=	-26.224	/	( ( 8.512	+	24.135 )	/ 2 )
	=	-26.224	/	16.3235
	=	-160.65 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

AcouSort AB (OSTO:ACOU) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

AcouSort AB ROCE % Related Terms

Thank you for viewing the detailed overview of AcouSort AB's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

AcouSort AB (OSTO:ACOU) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AcouSort AB (OSTO:ACOU) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

4SA:Germany

Address

Medicon Village, Lund, SWE, SE-223 81

Website

https://www.acousort.com

AcouSort AB is a company that specializes in products and solutions for the automated preparation of biological samples for researchers and life science companies. Its technology is based on using ultrasound to isolate, separate or trap microscopic particles such as blood cells, bacteria, or extracellular vesicles in microfluidic channels. The company products include AcouTrap, AcouWash, and AcouPlasma.

AcouSort AB (OSTO:ACOU) Headlines

No Headlines